What is Moderna's license agreement — cost of sales?

Moderna (MRNA) reported license agreement — cost of sales of $400.00M in Q4 2022.

What does license agreement — cost of sales mean?

The direct expenses incurred to generate revenue from licensing the company's proprietary technology or intellectual property to other firms.

Discontinued — last reported Q4 '22

Products & Services · Cost of Sales

License agreement — Cost of Sales

Analysis

StatementSegment

CategoryProfitability

SignalLower is better

VolatilityModerate

First reportedQ4 2022

Last reportedQ4 2022Feb 21, 2025

Rolls up toTotal Cost of Revenue

How to read this metric

An increase in this metric relative to licensing revenue may indicate higher royalty obligations or increased costs to maintain the underlying technology, potentially compressing margins. A decrease suggests improved cost efficiency or a shift toward higher-margin licensing agreements.

Detailed definition

This metric represents the direct costs associated with revenue generated from licensing intellectual property or techno...

Peer comparison

Peers in the biotechnology and pharmaceutical sectors often report similar costs under royalty expenses or cost of collaboration revenue, though accounting treatment varies based on the nature of the underlying IP rights.

Metric ID: mrna_segment_license_agreement_cost_of_sales

Historical Data

1 periods

	Q4 '22
Value	$400.00M

Similar Metrics at Other Companies

Natera, Inc.NTRA View metric

BiogenBIIB View metric

Warner Music GroupWMG View metric

Bristol-Myers SquibbBMY View metric

PTCPTC View metric

InsmedINSM View metric

Frequently Asked Questions

What is Moderna's license agreement — cost of sales?: Moderna (MRNA) reported license agreement — cost of sales of $400.00M in Q4 2022.
What does license agreement — cost of sales mean?: The direct expenses incurred to generate revenue from licensing the company's proprietary technology or intellectual property to other firms.